Mirion Technologies, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024
April 30, 2024 at 09:10 pm
Share
Mirion Technologies, Inc. reaffirmed earnings Guidance for the year ending December 31, 2024. The company expected revenue growth of 5% - 7%. Organic revenue growth of 4% - 6%.
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Medical and Technologies. The Medical segment includes products and services for radiation therapy and personal dosimetry. This segment's offerings include solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy; solutions for monitoring the total amount of radiation medical staff members are exposed to over time, and products for nuclear medicine in radiation measurement, shielding, product handling, medical imaging furniture and rehabilitation. The Technologies segment includes products and services for defense, nuclear energy, laboratories and research and other industrial markets. This segment's offerings include reactor safety and control systems, and radiological search, measurement and analysis systems.
MIRION TECHNOLOGIES, INC. 
